HCPCS Level IIdrugActive
J0583
Bivalirudin
BETOS: O1E
Effective: 2018-01-01
Description
Injection, bivalirudin, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Bivalirudin
Manufacturer
Sandoz Inc.
HCPCS Dosage
1 MG
Billing Units
250.0000
15
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.